Tersera Therapeutics
UEI: S8VHW1LQKEB7
• CAGE: 8NCG8
Overview
Parent Awardee
Name
Tersera Therapeutics
Headquarters
Bannockburn, IL
United States
United States
Federal recipient
TERSERA THERAPEUTICS LLC
(UEI S8VHW1LQKEB7, CAGE 8NCG8)
is headquartered in Bannockburn IL.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in January 2016 and
federally registered in
June 2020.
Federal Registration and Certifications
Legal Name
TERSERA THERAPEUTICS LLC
UEI
S8VHW1LQKEB7
CAGE Code
8NCG8
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 27, 2016
Initial Registration
June 2, 2020
Last Registration
Dec. 1, 2025
Registration Activation
Dec. 1, 2025
Registration Expiration
Nov. 30, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Manufacturer of Goods
Limited Liability Company
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No
People
Vendor contacts at Tersera Therapeutics
GSA Schedules and Price Lists
- Tersera Therapeutics
- PoP: 3/14/24 - 3/14/29